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ABSTRACT 
The dynamic modification of intracellular proteins by O-linked N-acetylglucosamine (O-GlcNAcylation) 
plays critical roles in many cellular processes. Although various methods have been developed for O-
GlcNAc detection, few techniques exist for monitoring glycosylation stoichiometry and state (i.e., mono-, 
di-, etc. O-GlcNAcylated). Yet, measuring the levels of O-GlcNAcylation on a given substrate protein is 
important for understanding the biology of this critical modification and for prioritizing substrates for 
functional studies. One powerful solution to this limitation involves the chemoenzymatic installation of 
polyethylene glycol polymers of defined molecular mass onto O-GlcNAcylated proteins. These “mass 
tags” produce shifts in protein migration during sodium dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS-PAGE) that can be detected by Western blotting. Broad adoption of this method by the scientific 
community has been limited, however, by a lack of commercially available reagents and well-defined 
protein standards. Here, we develop a “click chemistry” approach to this method using entirely commer-
cial reagents and confirm the accuracy of the approach using a semi-synthetic O-GlcNAcylated protein. 
Our studies establish a new, expedited experimental workflow and standardized methods that can be read-
ily utilized by non-experts to quantify O-GlcNAc stoichiometry and state on endogenous proteins in any 
cell or tissue lysate.  
 
INTRODUCTION 
O-GlcNAc glycosylation (or O-GlcNAcylation) is the covalent addition of the monosaccharide N-
acetylglucosamine to serine and threonine residues of intracellular proteins.
1-3
 This dynamic, inducible 
posttranslational modification is critical for vertebrate development and mammalian cell survival.
4-6
 
Moreover, the levels of O-GlcNAcylation are altered in many human diseases, including cancer, diabetes 
and neurodegenerative disorders.
7,8
 Several established and commercially available reagents have been 
developed for the identification and visualization of O-GlcNAcylated proteins.
9-11
 Despite the power of 
these methods, however, it remains challenging to measure the O-GlcNAc stoichiometry and state (mono-
, di-, etc. O-GlcNAcylated) on a given protein. Such information is often critical for identifying the key 
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2 
glycosylation events within a particular protein or pathway, such as those that are inducible, highly occu-
pied, or turned over rapidly, and for elucidating the molecular functions of O-GlcNAc. To address this 
challenge, we developed a chemoenzymatic method for the direct detection and quantification of endoge-
nous O-GlcNAc modification levels.
12,13
 Cell or tissue lysates are first reacted with a recombinant, mutant 
version of a bovine galactosyltransferase, GalT(Y289L), which transfers nonnatural analogs of N-
acetylgalactosamine from the corresponding uridine diphosphate (UDP) sugar-donors to the C-4 hydroxyl 
group of O-GlcNAc. These analogs contain bioorthogonal reactive groups that can be used to selectively 
install polyethylene glycol (PEG) polymer tags of defined molecular mass. The “mass tags” will cause the 
O-GlcNAcylated fraction of any protein to migrate slower during SDS-PAGE, thus enabling the determi-
nation of O-GlcNAc stoichiometry and state upon Western blotting. Previously, we extensively character-
ized a version of this chemoenzymatic strategy that involves the transfer of 2-keto-galactose, which is 
then appended with aminooxy-functionalized PEG via oxime formation (Figure 1A).
14
 However, the 
UDP-2-keto-galactose sugar is not commercially available, which limits broader adoption of this method 
by the scientific community. As such, we and others have focused on using GalT(Y289L) to transfer N-
azidoacetylgalactosamine (GalNAz) because the corresponding UDP-GalNAz donor sugar is available 
from various commercial sources. In this case, the PEG-tag can be installed using copper-catalyzed azide-
alkyne cycloaddition (CuAAC)
15-17
 or strain-promoted azide-alkyne cycloaddition (SPAAC) chemistry
18-
20
 using commercially available reagents (Figure 1B). The enzymatic modification step of this method has 
been well established, and commercial kits are now available based on those procedures to tag O-
GlcNAcylated proteins with small molecules such as biotin or fluorophores.
13
 However, no commercial 
vendor has established a protocol for labeling proteins with PEG polymers to determine O-GlcNAc stoi-
chiometries, and the reaction conditions for CuAAC and SPAAC used in academic labs have varied con-
siderably. Furthermore, the lack of pure O-GlcNAcylated protein standards of defined stoichiometry has 
made it difficult to systematically evaluate and optimize this method. Here, we first used protein semi-
synthesis to prepare a homogeneous O-GlcNAcylated protein. We then investigated and optimized the 
SPAAC chemoenzymatic mass tagging protocol for the quantitation of modification stoichiometry and 
state on both this protein standard and endogenous proteins in mammalian cell lysates. We found that 
previously published conditions using SPAAC can underrepresent O-GlcNAc stoichiometry, and demon-
strate complete labeling at the protein level using our significantly improved workflow. Our studies estab-
lish standardized methods using entirely commercially available reagents that can be readily utilized by 
non-experts to quantify O-GlcNAc stoichiometry on endogenous proteins in any cell or tissue lysate. 
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Figure 1. Quantification of O-GlcNAc stoichiometry by chemoenzymatic mass-tagging. (A) Endogenous 
O-GlcNAc modifications are first enzymatically modified by 2-keto-galactose before installation of a 
PEG mass-tag via oxime chemistry. The O-GlcNAcylated fraction of any given protein can then be meas-
ured by visualizing the slower migrating “mass-tagged” species by Western blotting. (B) Here, we opti-
mize the conditions for a similar procedure that utilizes strain-promoted cycloaddition (SPAAC) chemis-
try. 
 
RESULTS 
Previous reports using SPAAC to install PEG tags onto modified proteins have used different concentra-
tions of the cyclooctyne-functionalized PEG, ranging from 100 to 2000 µM.
18-20
 Furthermore, they have 
differed in their inclusion of an cysteine-alkylation step (i.e., iodoacetamide treatment), which can be used 
to reduce the background reactivity of common SPAAC tags with thiols.
21
 However, these reaction condi-
tions, to our knowledge, have not been directly compared or systematically evaluated for the chemoen-
zymatic quantification of O-GlcNAcylation stoichiometry. To accomplish this goal, we first used an ex-
pressed protein ligation (EPL) strategy to prepare a homogeneously modified protein (Figure 2A).
22
 Brief-
ly, HA-tagged ubiquitin was heterologously expressed in E. coli as a genetic fusion to a DnaE intein from 
Anabaena variabilis,
23
 resulting in the production of a recombinant ubiquitin-thioester. In parallel, we 
used solid-phase peptide synthesis to prepare an O-GlcNAcylated peptide (NH2-CGKSIAKgSIA-NH2, gS 
= O-GlcNAcylated serine), whose sequence was chosen for ease of ligation. An EPL reaction was then 
used to generate O-GlcNAcylated ubiquitin, which was purified by reversed-phase high-performance liq-
uid chromatography (RP-HPLC) and characterized by electrospray ionization mass spectrometry (ESI-
MS) (Figure S1), yielding highly pure protein of the correct mass. This O-GlcNAcylated ubiquitin protein 
standard was added to cell lysates, and the O-GlcNAcylated proteins were enzymatically modified with 
GalNAz by incubating with GalT(Y289L) and UDP-GalNAz. After precipitation to remove excess UDP-
GalNAz, the lysates were resuspended and incubated with different concentrations (250 to 1000 µM) of a 
5-kDa PEG chain linked to dibenzocylcootyne (DBCO-PEG, Click Chemistry Tools). The reactions were 
terminated after 16 h by the addition of SDS loading-buffer and the samples subjected to SDS-PAGE. 
Unfortunately, without a cysteine alkylation step, these samples could not be transferred to a PVDF 
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membrane using a semi-dry transfer system, presumably due to high background levels of protein 
PEGylation. We therefore repeated this experiment with the addition of an iodoacetamide treatment step 
directly after enzymatic modification. Precipitation was again used to remove the excess UDP-GalNAz 
and iodoacetamide before reaction with DBCO-PEG, SDS-PAGE, and Western blotting (Figure 2B). At 
all concentrations of DBCO-PEG tested, we observed a notable amount of PEGylation of O-
GlcNAcylated ubiquitin. However, the mass-tagging was not complete at concentrations lower than 1000 
µM, with the measured stoichiometry steadily increasing from 88% at 250 µM DBCO-PEG to 99% at 
1000 µM (Figure 2B). This suggests that previous reports using only 100 µM of DBCO-PEG likely un-
derestimated the O-GlcNAc stoichiometry of proteins. Additionally, the quantitative labeling of O-
GlcNAcylated ubiquitin using 1000 µM DBCO-PEG demonstrates that the enzymatic transfer of UDP-
GalNAz and subsequent SPAAC reaction indeed go to completion at the protein level.  
 
We next repeated the chemoenzymatic labeling protocol on cell lysates without the addition of O-
GlcNAcylated ubiquitin. Again, the proteins were subjected to SPAAC using a range of DBCO-PEG 
concentrations and resolved by SDS-PAGE. The mass-tagging of two known O-GlcNAcylated proteins, 
nucleoporin 62 (Nup62) and cyclic AMP-response element binding protein (CREB), was visualized by 
Western blotting (Figure 2C). Essentially all Nup62 in the cell has been shown to be O-GlcNAcylated at 
10 or more different sites, while approximately 30% of CREB is known to be O-GlcNAcylated in various 
brain tissues.
14,24
 Again, we found that treatment with DBCO-PEG concentrations less than 1000 µM re-
sults in incomplete labeling and underestimation of the O-GlcNAc stoichiometry. More specifically, the 
amounts of CREB modification increased from only 3% at 100 µM DBCO-PEG to 12% at 1000 µM in 
H1299 cells. Interestingly, as the mass-tagging became more quantitative on Nup62, the overall amount 
of shifted Nup62 is reduced. We interpreted this result as due to interference from excess PEG with SDS-
PAGE or Western blot. Therefore, we repeated the analysis of Nup62 and CREB with or without an addi-
tional precipitation step before SDS-PAGE to remove the unreacted PEG (Figure S2). Consistent with our 
hypothesis, we found that this final precipitation improved the overall signal and therefore incorporated 
this step into all of our subsequent analyses. However, a fraction of the total Nup62 signal appears to be 
lost as a result of the mass-shifting protocol. Notably, we do not see this with CREB or the semi-synthetic 
protein, indicating that this issue is most likely confined to high molecular-weight proteins or ones with a 
large number of O-GlcNAc modifications and could result from inefficient transfer or antibody recogni-
tion during the Western blot. 
 
With these optimized conditions in hand, we then set out to compare the SPAAC method to the CuAAC 
and oxime formation strategies.
14,15,17
 In the case of CuAAC, we subjected the GalNAz-labeled proteins to 
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5 
CuAAC conditions with alkyne-PEG (Click Chemistry Tools).
17
 For the oxime chemistry, we followed 
our previously published protocol
15
 for the enzymatic transfer of 2-keto-galactose, followed by reaction 
with 5-kDa aminooxy-PEG (Nanocs Inc.). First, we used lysates that had been doped with O-
GlcNAcylated ubiquitin and found that even aggressive CuAAC reaction conditions (24 h at 37 °C) re-
sulted in sub-stoichiometric labeling (Figure 3A). Consistent with our previous results, the oxime chemis-
try resulted in essentially quantitative mass-shifting that compares very well with SPAAC (Figure 3A). 
These results were also true for our analysis of the endogenous O-GlcNAcylated protein CREB, where 
the SPAAC and oxime chemistries again resulted in very similar measurements of O-GlcNAc stoichiome-
try (23 and 20%, respectively), and less mass tagging (11%) could be detected using CuAAC (Figure 3B). 
The increase in this stoichiometry compared to Figure 2C could be due to inclusion of a final precipitation 
step to remove the excess PEG (Figure 2S) or changes in CREB glycosylation as a part of normal H1299 
cell function.  
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Figure 2. Optimization of the mass-tagging protocol. (A) Synthesis of a site-specifically O-GlcNAcylated 
control protein. A recombinant, HA-tagged ubiquitin thioester was prepared using intein chemistry and 
was subsequently ligated to an O-GlcNAcylated peptide prepared by solid-phase peptide synthesis. (B) 
High concentrations of DBCO-PEG are required for quantitative mass shifting of the O-GlcNAcylated 
control protein. O-GlcNAcylated ubiquitin was added to cell lysates before enzymatic modification with 
GalNAz and reaction with the indicated concentrations of DBCO-PEG and analysis by Western blotting. 
(C) High concentrations of DBCO-PEG are also required for complete mass shifting of endogenous pro-
teins. Cell lysates were chemoenzymatically modified and the known O-GlcNAcylated proteins Nup62 
and CREB were visualized by Western blotting. 
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Figure 3. Comparison of mass-tagging with SPAAC with CuAAC or oxime formation. (A) Cell lysates 
were doped with O-GlcNAcylated biotin and subjected to enzymatic modification with either GalNAz 
(CuAAC and SPAAC) or 2-keto-galactose (Oxime) before bioorthogonal reaction with the appropriate 
PEG-tag and visualization by Western blotting. (B) Cell lysates were subjected as in (A) and the endoge-
nously O-GlcNAcylated proteins Nup62 and CREB were visualized by Western blotting. The quantifica-
tion is consistent in three different biological replicates. 
 
To ensure that our protocols were standardized using entirely commercially available reagents, we also 
compared our mass-tagging results, which used GalT(Y289L) expressed in our laboratory, to the com-
mercially available chemoenzymatic labeling kit from ThermoFisher Scientific (Click-iT O-GlcNAc En-
zymatic Labeling System). We find that both sources of enzyme result in highly similar levels of mass 
tagging on both Nup62 and CREB (Figure 4A). The fact that GalT(Y289L) is expressed in E. coli raises 
the possibility that contaminating bacterial proteins might cross-react with the antibodies employed to 
detect mammalian proteins of interest. To test this possibility, we immunoblotted four independent re-
combinant preparations of GalT(Y298L) using a handful of antibodies and found that, indeed, several 
antibodies recognize bacterial proteins of different molecular weights (Figure S3). We believe that these 
proteins are small levels of impurities due to incomplete washing of the inclusion bodies during 
GalT(Y298L) expression and purification. Therefore, we strongly recommend that researchers test their 
antibodies of choice with appropriate control experiments to rule out any misidentification of mass-tagged 
bands.  
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8 
To improve the overall efficiency of the method, we next asked whether the SPAAC reaction could be 
accelerated by heating, without negatively affecting its selectivity. Accordingly, we performed chemoen-
zymatic labeling of O-GlcNAcylated ubiquitin or cell lysates as previously described, followed by 
SPAAC at 25 °C for 16 h as above or at 98 °C for 5 min. Remarkably, we found that these “boiling” con-
ditions result in selective SPAAC and indistinguishable mass shifts (Figure 4B). No mass shifts were ob-
served with an O-GLcNAc-deficient mutant of CREB
24
 using either room temperature or boiling condi-
tions (Figure S4), further confirming the selectivity of  the approach. The ability to achieve quantitative 
chemoenzymatic labeling within minutes reduces the overall time required for the mass-tagging proce-
dure by about one-half. 
 
Figure 4. Further characterization of chemoenzymatic mass-tagging by SPAAC. (A) Commercial reagents 
are sufficient for O-GlcNAc quantitation. Cell lysates were subjected to the SpAAC mass-tagging proto-
col using purified GalT or commercially available enzyme (ThermoFisher Scientific) before Western 
blotting. (B) SPAAC proceeds selectively and quantitatively in 5 min at 98 °C. O-GlcNAcylated ubiquitin 
was added to H1299 lysates and enzymatically labeled. SPAAC was then performed at either room tem-
perature for 16 h or 98 °C for 5 min. Notably, we found that 98 °C for 5 min results in quantitative label-
ing and does not increase non-specific background. 
 
 
Finally, DBCO-PEG has limited solubility in DMSO. Therefore, increasing its concentration resulted in 
higher percentages of DMSO in the above SPAAC reactions (up to 10% DMSO at 1000 µM). This raised 
the possibility that increased amounts of DMSO could result in improved mass-shifting at lower DBCO-
PEG concentrations. To examine this further, we repeated the chemoenzymatic mass-shifting of O-
GlcNAcylated ubiquitin with DBCO-PEG (100 - 1000 µM) in the presence of 10% DMSO at room  tem-
perature for 16 h (Figure S5A). We observed a small improvement in the SPAAC reaction at lower con-
centrations of DBCO-PEG (compare to Figure 2B) but found that com-plete mass-shifting still required 
1000 µM DBCO-PEG. Notably, this was also true when we per-formed the SPAAC reaction at 98 °C for 
5 min (Figure S5B). 
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9 
In summary, we have developed an SPAAC-based approach for the determination of O-GlcNAc stoichi-
ometry and state using entirely commercially available reagents. This method was significantly improved, 
systematically optimized, and validated for the first time on the protein level using a pure, semi-synthetic 
O-GlcNAcylated protein standard.  Our results suggest that several previously published SPAAC proto-
cols may result in an underestimation of O-GlcNAcylation stoichiometry. Importantly, the protocol de-
veloped here does not require mass spectrometry or other advanced instrumentation and can be performed 
using commercially available reagents from ThermoFisher Scientific and Click Chemistry Tools, which 
will empower non-experts to explore their own proteins of interest. We believe that these expedited, high-
ly accessible procedures will both standardize and expand the application of this powerful mass tagging 
strategy for the analysis of O-GlcNAcylation stoichiometry and state. 
 
 
DETAILED PROTOCOL FOR SPAAC 
Buffers and reagents needed: 
 0.05% SDS buffer (0.05% SDS, 150 mM NaCl, 10 mM TEA pH 7.4) 
 4% SDS buffer (4% SDS, 150 mM NaCl, 10 mM TEA pH 7.4) 
 1% SDS Buffer (1% SDS, 150 mM NaCl, 10 mM TEA pH 7.4) 
 1% SDS GalT buffer (1% SDS with 20 mM HEPES pH 7.9) 
 GalT as supplied by Invitrogen Click-IT Kit or produced in-house 
 Labeling Buffer (2.5 X; 5% NP-40 (or IGEPAL® CA-630), 125 mM NaCl, 50 mM HEPES pH 7.9), 
supplied by Invitrogen Click-IT Kit or made in-house 
 MnCl2 (100 mM in H2O), supplied by Invitrogen Click-IT Kit or made in-house 
 UDP-GalNAz (0.5 mM in 10 mM HEPES pH 7.9), supplied by Invitrogen Click-It Kit or made in-house 
(see Supporting Information) 
 Iodoacetamide (made fresh, 600 mM stock in H2O)  
 DBCO-PEG-5K (10 mM stock DMSO) from Click Chemistry Tools 
 2 × loading buffer (20% glycerol, 0.2% bromophenol blue, 1.4% β-mercaptoethanol, pH 6.8) 
 cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail from Roche Biosciences 
 Benzonase from EMD Millipore 
Control antibodies for Western blotting: 
•Anti-CREB1, 9104S, Cell Signaling Technology 
•Anti-Nup62, 610497, BD Biosciences 
Step-by-step protocol: 
 Collect cells and wash twice with PBS (1 x 10 cm dish at ≥80% confluency) 
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 Add 26 µL of H2O containing 10X c0mplete mini protease inhibitor cocktail (Sigma Aldrich) 
 Add 50 µL of 0.05% SDS buffer and resuspend cells 
 Add 1 µL of benzonase and incubate on ice for 30 min 
 Add 200 µL of 4% SDS buffer 
 Vortex and pellet any debris by centrifugation at 10,000 x g, 10 min, 15 °C 
 Perform BCA assay and normalize protein concentration to 1 µg/µL using 1% SDS buffer 
 To 1 mg of protein (1000 µL) 
I. Add 3000 µL of methanol and vortex 
II. Add 750 µL of chloroform and vortex 
III. Add 2000 µL of H2O and vortex 
IV. Centrifuge at 5,000 x g, 5 mins, 15 °C 
V. Discard the upper aqueous phase, while leaving the interface layer interacted 
VI. Add 2250 µL of methanol and vortex 
VII.  Centrifuge at 5,000 x g, 10 mins, 15 °C and discard the supernatant 
VIII.  Allow pellet to air dry for 5 min. Note: Do not allow the protein pellet to “over-dry,” as 
this will make the proteins difficult to resuspend. This is true for all subsequent drying steps. 
 Resuspend protein in 100 µL 1% SDS GalT buffer 
 Bath sonicate until proteins are dissolved 
 Perform BCA assay and normalize protein concentration to 2.5 µg/µL using 1% SDS GalT buffer 
 Add enzymatic reagents in the following order for “+GalT + UDP sample” 
I. 40 µL of Lysate 
II. 49 µL of H2O  
III. 80 µL of Labeling Buffer  
IV. 11 µL MnCl2  
V. 10 µL UDP-GalNAz 
VI. 10 µL GalT enzyme 
 Add enzymatic reagents in the following order for “-GalT + UDP sample” 
I. 40 µL of Lysate 
II. 59 µL of H2O  
III. 80 µL of Labeling Buffer  
IV. 11 µL MnCl2  
V. 10 µL UDP-GalNAz 
 Optional: Add enzymatic reagents in the following order for “+GalT - UDP sample” 
I. 40 µL of Lysate 
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II. 59 µL of H2O  
III. 80 µL of Labeling Buffer  
IV. 11 µL MnCl2  
V. 10 µL GalT enzyme 
 Incubate samples at 4 °C for 20 h 
 Add 7.5 µL of freshly made iodoacetamide (600 mM) to each sample 
 Incubate for 30 min in the dark 
 To each sample 
I. Add 622 µL of methanol and vortex 
II. Add 156 µL of chloroform and vortex 
III. Add 415 µL of H2O and vortex 
IV. Centrifuge at 10,000 x g, 5 mins, 15 °C 
V. Discard the upper aqueous phase, while leaving the interface layer intact 
VI. Add 467 µL of methanol to tube and vortex 
VII.  Centrifuge at 10,000 x g, 10 mins, 15 °C and discard the supernatant 
VIII.  Allow pellet to air dry for 5 min 
 Add 90 µL of 1% SDS and bath sonicate until proteins are dissolved 
 Add 10 µL of DBCO-PEG-5K and vortex 
 Incubate for 16 hours at room temperature OR boil for 5 min at 98 °C 
 To each sample 
I. Add 300 µL of methanol and vortex 
II. Add 75 µL of chloroform and vortex 
III. Add 200 µL of H2O and vortex 
IV. Centrifuge at 10,000 x g, 5 mins, 15 °C 
V. Discard upper aqueous phase while leaving the interface layer intact 
VI. Add 225 µL of methanol to tube and vortex 
VII.  Centrifuge at 10,000 x g, 10 mins, 15 °C and discard the supernatant 
VIII.  Allow pellet to air dry for 5 min 
 Add 25 µL of 4% SDS and bath sonicate until proteins are dissolved 
 Add 25 µL of 2x SDS and boil for 5 mins at 98 °C  
 Load ~40 µg per lane on SDS-PAGE for Western blotting 
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